EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSNGAG00000000887
Gene Symbol: MAP3K9
3 Cross references
194 Possible Orthologues:

Monoamine Oxidase A

Ensembl ID : ENSNGAG00000013137
Gene Symbol: MAOA
3 Cross references
147 Possible Orthologues:

Monoamine Oxidase B

Ensembl ID : ENSNGAG00000016015
Gene Symbol: MAOB
3 Cross references
329 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSNGAG00000013544
Gene Symbol: MGLL
3 Cross references
208 Possible Orthologues:

Multidrug Resistance Protein 1

Ensembl ID : ENSNGAG00000017731
Gene Symbol: LOC103725178
2 Cross references
147 Possible Orthologues:

Multidrug Resistance Protein 2

Ensembl ID : ENSNGAG00000024146
Gene Symbol: LOC103725176
3 Cross references
148 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSNGAG00000016937
Gene Symbol: MPO
1 Cross references
181 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSNGAG00000011425
Gene Symbol: NPR1
3 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSNGAG00000012144
Gene Symbol: NPR2
3 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSNGAG00000012180
Gene Symbol: NPR3
3 Cross references
211 Possible Orthologues:

Neprilysin-Like

Ensembl ID : ENSNGAG00000012862
Gene Symbol: LOC103726236
2 Cross references
235 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSNGAG00000013389
Gene Symbol: LOC103748066
3 Cross references
243 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).